Rapid acting antidepressants
Author(s)
Bibliographic Information
Rapid acting antidepressants
(Advances in pharmacology / edited by Silvio Garattini [and] Parkhurst A. Shore, 89)
Academic Press, 2020
- hbk.
Available at 2 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Description and Table of Contents
Description
The Advances in Pharmacology series presents a variety of chapters from the best authors in the field.
Table of Contents
Part I - Neurobiology of ketamine effects
Effects of ketamine and other rapidly acting antidepressants on hippocampal excitatory and inhibitory transmission
Allie J. Widman and Lori L. McMahon
Antidepressant mechanisms of ketamine: Focus on GABAergic inhibition
Bernhard Luscher, Mengyang Feng and Sarah J. Jefferson
The role of eEF2 kinase in the rapid antidepressant actions of ketamine
Kanzo Suzuki and Lisa M. Monteggia
Part II - The rapid therapeutic effects of ketamine
Clinical overview of NMDA-R antagonists and clinical practice
Pasha A. Davoudian and Samuel T. Wilkinson
Ketamine for depression clinical issues
Syed Z. Iqbal and Sanjay J. Mathew
Chronic stress pathology and ketamine-induced alterations in functional connectivity in major depressive disorder: An abridged review of the clinical evidence
Lynnette A. Averill, Samar Fouda, James W. Murrough and Chadi G. Abdallah
Neurobiological biomarkers of response to ketamine
Bashkim Kadriu, Elizabeth D. Ballard, Ioline D. Henter, Stephen Murata, Nimesha Gerlus and Carlos A. Zarate Jr
Relapse prevention in treatment resistant major depressive disorder with rapid-acting antidepressants
Jaskaran B. Singh, Maggie Fedgchin, Ella J. Daly and Wayne C. Drevets
The emergence of ketamine as a novel treatment for posttraumatic stress disorder
Adriana Feder, Sarah B. Rutter, Daniela Schille and Dennis S. Charney
Part III - Novel rapid-acting antidepressant mechanisms related to ketamine
mGlu2/3 receptor as a novel target for rapid acting antidepressants
Shigeyuki Chaki
Involvement of muscarinic receptor mechanisms in antidepressant drug action
Jeffrey M. Witkin, Jodi L. Smith, Lalit K. Golani, Emily A. Brooks and Anna E. Martin
The antidepressant efficacy of the muscarinic antagonist scopolamine: Past findings and future directions
Wayne C. Drevets, Anindya Bhattacharya and Maura L. Furey
by "Nielsen BookData"